#Blog

Access
All Articles




Radio Compass Blog

Trump says Pfizer’s vaccine likely to be first Covid vaccine available; Dr Reddy’s settles blockbuster patent suit with BMS

This week, Phispers has lots of updates on experimental vaccines for Covid-19. US President Donald Trump has said Pfizer could get an approval in the coming weeks for its vaccine. Four drugmakers shared comprehensive roadmaps on how they are eval...
2020-09-24

https://www.pharmacompass.com/radio-compass-blog/trump-says-pfizer-s-vaccine-likely-to-be-first-covid-vaccine-available-dr-reddy-s-settles-blockbuster-patent-suit-with-bms

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 9415
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Gilead acquires Immunomedics for US$ 21 billion; FDA issues guidance on resuming normal manufacturing

This week, Phispers brings you news of two deals in the antibody drug conjugates (ADCs) space. While Gilead bought cancer drugmaker Immunomedics for US$ 21 billion for its ADC drug Trodelvy, Merck got into a deal with Seattle Genetics to develop it...
2020-09-17

https://www.pharmacompass.com/radio-compass-blog/gilead-acquires-immunomedics-for-us-21-billion-fda-issues-guidance-on-resuming-normal-manufacturing

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 35140
Share Share info

#PharmaFlow

Access
Interactive
Dashboard




Radio Data Compilation Dashboards

USFDA’s list of drugs that need generic alternatives

In its continuous endeavor to bolster the competitiveness of the generics market, the US Food and Drug Administration (FDA) updated its list of ‘off-patent, off-exclusivity drugs without an approved generic’. The ...
2020-09-16

https://www.pharmacompass.com/radio-compass-blog/usfda-s-list-of-drugs-that-need-generic-alternatives

#PharmaFlow by PHARMACOMPASS PharmaCompass on Linkedin
Views: 40827
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

CEOs pledge to prioritize science for safe Covid vaccine; AstraZeneca-Oxford put phase 3 trials on hold

This week, Phispers brings you crucial news on vaccine development to control the ongoing Covid-19 pandemic. In the US, in a move that appears to undermine the rhetoric around launching a Covid-19 vaccine before the Presidential elections, CEO...
2020-09-10

https://www.pharmacompass.com/radio-compass-blog/ceos-pledge-to-prioritize-science-for-safe-covid-vaccine-astrazeneca-oxford-put-phase-3-trials-on-hold

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 52098
Share Share info

#PharmaFlow

Access
Interactive
Dashboard




Radio Data Compilation Dashboards

DMF submissions in 2020: Industry sustains its filing momentum

In case you thought Covid-19 had slowed down the speed at which generic active pharmaceutical ingredient (API) manufacturers were submitting Drug Master Files (DMFs) to the US Food and Drug Administration (FDA), you are in for a pleasant surprise....
2020-09-03

https://www.pharmacompass.com/radio-compass-blog/dmf-submissions-in-2020-industry-sustains-its-filing-momentum

#PharmaFlow by PHARMACOMPASS PharmaCompass on Linkedin
Views: 55556
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Another Mylan unit gets FDA warning letter; US may fast-track Covid-19 vaccine, says FDA chief

This week, Phispers brings you news on Nestle as it bought peanut allergy treatment maker Aimmune Therapeutics for US$ 2 billion. Mylan saw another one of its plants in India receive a warning letter for inadequate management of recovered solvents....
2020-09-03

https://www.pharmacompass.com/radio-compass-blog/another-mylan-unit-gets-fda-warning-letter-us-may-fast-track-covid-19-vaccine-says-fda-chief

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 47422
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Teva faces drug price fixing charges, to cut 350 jobs in Israel; Wintac gets hit by FDA Warning Letter

This week, Phispers brings you more updates on Japanese drugmaker Takeda and Israeli drug giant Teva. While Takeda sold its consumer healthcare business to Blackstone to reduce the debt it had incurred from buying Shire last year, Teva decided to c...
2020-08-27

https://www.pharmacompass.com/radio-compass-blog/teva-faces-drug-price-fixing-charges-to-cut-350-jobs-in-israel-wintac-gets-hit-by-fda-warning-letter

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 50474
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

FDA gets embroiled in electoral politics; grants EUA to convalescent plasma therapy

With US President Donald Trump getting more aggressive at dealing with widespread criticism over how he mishandled the ongoing Covid-19 pandemic, the US Food and Drug Administration (FDA) is increasingly getting embroiled in electoral politics. ...
2020-08-27

https://www.pharmacompass.com/radio-compass-blog/fda-gets-embroiled-in-electoral-politics-grants-eua-to-convalescent-plasma-therapy

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 24926
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

US sues Teva over kickbacks, stock drops; J&J, Sanofi announce big deals

This week, Phispers is packed with news on M&As. Johnson & Johnson acquired Momenta Pharmaceuticals for US$ 6.5 billion to strengthen its autoimmune drug pipeline. Sanofi acquired Principia Biopharma for US$ 3.7 billion. BMS signed a US$ ...
2020-08-20

https://www.pharmacompass.com/radio-compass-blog/us-sues-teva-over-kickbacks-stock-drops-j-j-sanofi-announce-big-deals

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 51041
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Kodak’s US$ 765 million loan put on hold; Digital health sees its biggest deal as Teladoc buys Livongo

This week, Phispers brings you news about the world’s first Covid-19 vaccine bagging clearance in Russia, even though its clinical trials are far from over. Expectedly, experts are skeptical about its safety and efficacy. Digital health saw i...
2020-08-13

https://www.pharmacompass.com/radio-compass-blog/kodak-s-us-765-million-loan-put-on-hold-digital-health-sees-its-biggest-deal-as-teladoc-buys-livongo

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 49586
Share Share info
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty